Latest News

Alzheon, Inc. | ALZH Stock | Biotech Firm Seeking to Raise...

Alzheon
Alzheon, a biotech firm developing small molecule therapies targeted at Alzheimer's disease, is set to go public on Wednesday, October 24, 2018. The company laid...

Axonics Modulation Technologies | AXNX Stock | Med Tech Lays Out...

Axonics Modulation Technologies
Axonics Modulation Technologies, a medical technology firm that focuses on the design, development, and commercialization of innovative implantable sacral neuromodulation devices is planning to...

Yeti Sets Terms for its Renewed IPO

Yeti
Yeti Holdings, Inc. (NYSE: YETI) Yeti Holdings, Inc, a high-end cooler maker based in Austin, has set the terms of its $400 million initial public...

Tencent Music Entertainment Delays IPO Due To Market Conditions

Tencent Music Entertainment
Tencent Music Entertainment Group has put off its initial public offering until at least November, according to a report by Wall Street Journal. Sources familiar...

NIO Inc. | $NIO Stock | Shares Rocket Higher On...

NIO
NIO Inc. (NYSE: NIO)   On Tuesday October 9th, 2018, shares of a little-known IPO that debuted on the New York Stock Exchange last month began...

SolarWinds | $SWI Stock | IT Software Firm Seeking to Raise...

SolarWinds is planning to go public nearly two years after it was taken private by Silver Lake Group LLC and Thoma Bravo LLC in...

Allogene Therapeutics Looking To Raise $272 Million In IPO

Allogene Therapeutics
Allogene Therapeutics (NASDAQ: ALLO)   Allogene Therapeutics, a clinical-stage biotech firm developing allogenic CAR T cell cancer therapies, filed for an initial public offering with the...

Anaplan, Inc | PLAN Stock | Cloud Software Company Looking To...

Anaplan
Anaplan, a California-based tech firm that provides cloud-based business planning software and services, filed for an initial public offering with the U.S. Securities and...

Guardant Health | $GH Stock | Liquid Biopsy Maker Seeking To...

Guardant Health
Guardant Health, a U.S. oncology company that focuses in cancer detection through blood tests, is hoping to raise $200 million by selling 12,500,000 shares...